SYNGENE

Syngene International Balance Sheet

₹360.10-0.85%
Market cap
₹14,468 crore
P/E
65.5
P/B
2.99
ROE
6.6%
Dividend yield
0.35%

As of Mar 2022, Syngene International had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings rose 47.20% from Mar 2023.

Syngene International balance sheet

As at each financial year end, newest first. H1 = half-year.

Syngene International balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital500401402403403
Reserves8,5002,9733,4363,8824,149
Borrowings1,200815555578458
Other liabilities3,5001,3981,3391,4911,757
Total liabilities13,7005,8316,1526,7967,055
Fixed assets6,5002,7933,6254,0313,976
Capital work in progress400100100100100
Investments2,5001,1661,2301,3591,411
Other assets4,3001,7491,8452,0392,116
Total assets13,7005,8316,1526,7967,055

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Syngene International balance sheet — frequently asked questions

What is the total debt of Syngene International?

Syngene International reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹815 crore as of Mar 2023.

What is Syngene International's debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Syngene International's debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Syngene International's total assets?

Syngene International's total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Syngene International With ATS

Track SYNGENE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.